comprehensive -WSS

comprehensive

author：leisure time 2025-09-28 23:49:08 - browse：57

President Biden's White House announced the first 10 medicines that will be up first in its new drug price negotiation program. Anna Moneymaker/Getty Images

WASHINGTON — Medicare on Tuesday announced it will negotiate prices for 10 drugs, including major blood thinners and diabetes medications, in the first round of its negotiation program created in Democrats’ drug pricing reform law.

The drugs include Bristol Myers Squibb’s blood thinner Eliquis, Boehringer Ingelheim and Eli Lilly’s diabetes drug Jardiance, Johnson & Johnson’s blood thinner Xarelto, Merck’s diabetes drug Januvia, AstraZeneca’s diabetes drug Farxiga, Novartis’ heart failure treatment Entresto, Amgen’s rheumatoid arthritis drug Enbrel, Johnson & Johnson and AbbVie’s blood cancer treatment Imbruvica, J&J’s anti-inflammatory medicine Stelara, and Novo Nordisk insulins that go by names including Fiasp and NovoLog.

The new prices will be announced on Sept. 1, 2024, and will go into effect on Jan. 1, 2026. The drugs were chosen from a list of 50 treatments that cost Medicare’s pharmacy drug benefit the most money. The selected medicines cost Medicare more than $50 billion and made up 20% of the Medicare program’s pharmacy drug costs over a one-year period, the Department of Health and Human Services said. (Read more here about the winners and losers of the selection.)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： BioMarin wins approval for gene therapy to treat hemophilia A

WSS

BMS, looking to build heart drug business, turns to AI for diagnosis

What does generative AI mean for health care? We asked experts

How one medical school became remarkably diverse

23andMe had bad news about my health. I wish a person had delivered it

Senators push IRS to launch nonprofit hospital probe

Activists slam private health insurers over coverage restrictions

entertainment

comprehensive

entertainment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

After Optum profits sink, UnitedHealth makes changes

Dobbs anniversary: the lost opportunity of abortion as health care

Be careful with at

ChatGPT in medicine: STAT answers readers' burning questions

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

At least 13 dead in Texas as scorching temps continue

Bird flu researchers hone in on Finland’s mink farms

Medicare proposal to cover medical devices draws a mixed reaction

In Memoriam: Notable people who died in 2023

explore

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

Be careful with at

Bright Health sells Medicare Advantage business to Molina

Illumina slashes 2023 revenue projections yet again

Bird flu researchers hone in on Finland’s mink farms

Cancer drug shortages should be causing more outrage

entertainment

hotspot

hotspot

leisure time